multiple myeloma

News

J&J bids to add smouldering myeloma to Darzalex label

Johnson & Johnson has reported positive phase 3 data with Darzalex in smouldering multiple myeloma (SMM), just before filing applications for the drug in this indication in Europe and t

News

Joy as NICE lifts restrictions on myeloma drug Elrexfio

Patients in England and Wales with multiple myeloma are celebrating a decision by NICE to relax strict restrictions on eligibility to receive Pfizer's Elrexfio.

R&D

Myeloma multiplex leukaemia cancer 3D render

The future of multiple myeloma is personalised, but we must ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma.

News

Sanofi's Sarclisa gets one up on rival Darzalex in myeloma

Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson and Genmab's blockbuster Darzalex, but now has a chance to steal some of the spotlight.

News

NICE updates on controversial multiple myeloma decisions

NICE has defended a trio of decisions on new therapies for multiple myeloma, which saw two drugs approved for restricted use in England and Wales and a third turned down altogether.

News

GSK files Blenrep in EU, seeking return to market

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its bloc

J&J bids to add smouldering myeloma to Darzalex label

Joy as NICE lifts restrictions on myeloma drug Elrexfio

The future of multiple myeloma is personalised, but we must ...

Sanofi's Sarclisa gets one up on rival Darzalex in myeloma

NICE updates on controversial multiple myeloma decisions

GSK files Blenrep in EU, seeking return to market

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

multiple myeloma

Editor's Picks